Evidence map›Paper›PMID 22378906›Full record

ArticleJournal of clinical microbiology2012

mecA-positive Staphylococcus aureus with low-level oxacillin MIC in Taiwan.

Feng-Jui Chen, I-Wen Huang, Chen-Her Wang, Pei-Chen Chen, Hui-Yin Wang, Jui-Fen Lai, Yih-Ru Shiau, Tsai-Ling Yang Lauderdale, TSAR Hospitals

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Oxacillin-susceptible methicillin-resistantJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025
    Article
  3. Article
  4. Mec-A Positive Methicillin-SusceptibleReports of biochemistry & molecular biology · 2024
    Article
  5. Article
  6. Article
  7. Antibiotic Resistance Profile and Biofilm Production ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
  8. Article
  9. First Report of Oxacillin SusceptibleInfection and drug resistance · 2021
    Article
  10. Distribution and antibiotic-resistance of differentJournal of oral microbiology · 2021
    Article
  11. Article
  12. Article
  13. Antimicrobial Resistance in ESKAPE Pathogens.Clinical microbiology reviews · 2020
    Review
  14. Article
  15. Article
  16. Control of Methicillin-ResistantFrontiers in microbiology · 2020
    Article
  17. Emergence of Oxacillin Resistance in Stealth Methicillin-ResistantAntimicrobial agents and chemotherapy · 2019
    Article
  18. Article
  19. Dissemination Of t437-SCCInfection and drug resistance · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Feng-Jui ChenDivision of Infectious Diseases, National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
I-Wen Huang
Chen-Her Wang
Pei-Chen Chen
Hui-Yin Wang
Jui-Fen Lai
Yih-Ru Shiau
Tsai-Ling Yang Lauderdale
TSAR Hospitals

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the presence of mecA is the genotypic determinant of methicillin-resistant Staphylococcus aureus (MRSA), certain MRSA strains, especially community-associated MRSA (C-MRSA), can display an oxacillin MIC in the Clinical and Laboratory Standards Institute susceptible breakpoint range (≤ 2 μg/ml). Among 91 and 180 isolates thought to be methicillin-susceptible S. aureus (MSSA) with oxacillin MICs of 2 and 1 μg/ml as determined by the Sensititre broth microdilution test initially, 52 (57.1%) and 6 (3.3%), respectively, were mecA positive. These mecA-positive low-oxacillin-MIC isolates belong to the dominant Taiwan C-MRSA clone (clonal complex [CC] 59), 56 of which carried SCCmec type V and were pvl positive, and 43 of which belonged to spa CC t437. All 271 isolates were retested by Sensititre, as well as by Vitek II and disk diffusion (DD). Based on the oxacillin results, the sensitivities of the Sensititre, Vitek II, and DD methods were 48.3% (28/58), 46.6% (27/58), and 89.6% (52/58), respectively. Although cefoxitin was better at detecting these isolates, 12.1, 10.4, and 5.2% of these isolates were still misidentified as MSSA by Sensititre, Vitek II, and DD, respectively. These results highlight the difficulty in the accurate identification of MRSA with borderline oxacillin MICs in the CC59:SCCmec V clone, which likely has contributed to its spread in the health care and community settings. Since this clone has now been detected in other countries, and since other C-MRSA lineages have also been found to have low-level β-lactam resistance, the findings of the present study may be relevant to other regions. Further studies are warranted to determine the extent and clinical impact of such misidentification.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBacterial ProteinsChildChild, PreschoolFemaleGenotypeHumansInfantInfant, NewbornMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial ProteinsmecA protein, Staphylococcus aureusOxacillinPenicillin-Binding Proteins

Identifiers

PMID22378906
PMCPMC3347131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.